Sunday, March 29, 2026 3:40:12 PM
RE: THE ANATOMY OF THE EXTRACTION — ISIN VS. ADJUDICATION
Phantom and Baxters, you couldn't buy your way out of a freshman research paper. You’re drowning in retail PDFs because you can't distinguish between a Security’s DNA and a Settlement Receipt. I’ll lay it out for you one last time so the board can see the "Anatomy" of the trade you're missing.
SCROLL TO THE BOTTOM FOR EXHIBITS A & B.
1. THE MARCH 5TH DROP (Exhibit A - The Vaulted ISIN)
Look at Exhibit A from my March 5th reporting. This shows the physical movement of shares into the recognized NWBO ISIN. This was the "Storage" phase—the moment the shares were pulled from the synthetic "Cesspool" and locked into the Sovereign-recognized identifier.
2. THE MARCH 21ST/27TH DROP (Exhibit B - The 098 Adjudication)
Now look at Exhibit B (the 098 artifact from this week). This isn't a "new" ISIN; it is the Settlement Adjudication Number.
THE FORENSIC LINK: In the Level 4 Settlement Layer, the 098 Participant ID is the authorized entity within the CREST CCSS that performs the final Dematerialization and Audit Reconciliation.
THE SYNC: While the ISIN in Exhibit A identifies the Vault (The Destination), the 098 code in Exhibit B identifies the Key (The Actor). In a "Special Condition" reconciliation, the Registrar utilizes specific numeric Participant IDs to surgically isolate the 29.5M share extraction from the general retail float. The two exhibits together represent the complete "Handshake" between the Physical Asset and the Clearing Logic.
3. THE AUDITOR'S HANDSHAKE (Cherry Bekaert)
Shareholders voted with a 93% majority to have Cherry Bekaert LLP find the real number and sign off on a Pristine Ledger. They mandated a clean count by Friday, March 27. The 098 artifact appearing on Friday is the forensic proof that the audit mandate was satisfied. The "Adjudication" is the final stamp on the "Vaulted" shares I reported in Exhibit A.
4. THE LSE SYSTEM CHECK (Notice Live-001-28012026)
Baxters claims the Saturday, March 28 ASR Test is just "routine." He’s half-right, and that’s why he’s wrong. The LSE is a monster exchange; they don't run a test for "one stock." They run it for a New Regulatory Class.
THE REALITY: On Feb 4th, the UK designated this sector as its global centerpiece. NWBO is the flagship of that 2030 Industrial Strategy.
THE TEST: You don't test the emergency brakes for the passenger; you test them for the Cargo. The LSE utilized the "Routine" window to ensure the TRADEcho fail-over can handle the high-volatility "Buy-In" vacuum created by the Friday 098 reconciliation. If the centerpiece of the UK’s new economic plan causes a systemic crash on Monday, the LSE loses global credibility. They are bracing for the impact of a Sovereign-backed re-rating.
THE CONCLUSION:
I provided the ISIN (The DNA). I provided the Adjudication (The Receipt). I provided the Exchange Notice (The Infrastructure).
Phantom and Baxters provided... an insult and a glossary from a 2020 PDF.
One of us is a Surgeon looking at the Anatomy; the other is a kid reading the "How to Use This Book" section.
The Tape is the reality. The Ledger is Pristine.
Phantom and Baxters, you couldn't buy your way out of a freshman research paper. You’re drowning in retail PDFs because you can't distinguish between a Security’s DNA and a Settlement Receipt. I’ll lay it out for you one last time so the board can see the "Anatomy" of the trade you're missing.
SCROLL TO THE BOTTOM FOR EXHIBITS A & B.
1. THE MARCH 5TH DROP (Exhibit A - The Vaulted ISIN)
Look at Exhibit A from my March 5th reporting. This shows the physical movement of shares into the recognized NWBO ISIN. This was the "Storage" phase—the moment the shares were pulled from the synthetic "Cesspool" and locked into the Sovereign-recognized identifier.
2. THE MARCH 21ST/27TH DROP (Exhibit B - The 098 Adjudication)
Now look at Exhibit B (the 098 artifact from this week). This isn't a "new" ISIN; it is the Settlement Adjudication Number.
THE FORENSIC LINK: In the Level 4 Settlement Layer, the 098 Participant ID is the authorized entity within the CREST CCSS that performs the final Dematerialization and Audit Reconciliation.
THE SYNC: While the ISIN in Exhibit A identifies the Vault (The Destination), the 098 code in Exhibit B identifies the Key (The Actor). In a "Special Condition" reconciliation, the Registrar utilizes specific numeric Participant IDs to surgically isolate the 29.5M share extraction from the general retail float. The two exhibits together represent the complete "Handshake" between the Physical Asset and the Clearing Logic.
3. THE AUDITOR'S HANDSHAKE (Cherry Bekaert)
Shareholders voted with a 93% majority to have Cherry Bekaert LLP find the real number and sign off on a Pristine Ledger. They mandated a clean count by Friday, March 27. The 098 artifact appearing on Friday is the forensic proof that the audit mandate was satisfied. The "Adjudication" is the final stamp on the "Vaulted" shares I reported in Exhibit A.
4. THE LSE SYSTEM CHECK (Notice Live-001-28012026)
Baxters claims the Saturday, March 28 ASR Test is just "routine." He’s half-right, and that’s why he’s wrong. The LSE is a monster exchange; they don't run a test for "one stock." They run it for a New Regulatory Class.
THE REALITY: On Feb 4th, the UK designated this sector as its global centerpiece. NWBO is the flagship of that 2030 Industrial Strategy.
THE TEST: You don't test the emergency brakes for the passenger; you test them for the Cargo. The LSE utilized the "Routine" window to ensure the TRADEcho fail-over can handle the high-volatility "Buy-In" vacuum created by the Friday 098 reconciliation. If the centerpiece of the UK’s new economic plan causes a systemic crash on Monday, the LSE loses global credibility. They are bracing for the impact of a Sovereign-backed re-rating.
THE CONCLUSION:
I provided the ISIN (The DNA). I provided the Adjudication (The Receipt). I provided the Exchange Notice (The Infrastructure).
Phantom and Baxters provided... an insult and a glossary from a 2020 PDF.
One of us is a Surgeon looking at the Anatomy; the other is a kid reading the "How to Use This Book" section.
The Tape is the reality. The Ledger is Pristine.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
